ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Shares Sold by Trexquant Investment LP
Trexquant Investment LP trimmed its holdings in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 33.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,563 shares of the company’s stock after selling 28,732 shares during the quarter. Trexquant Investment LP owned […]
